BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23286293)

  • 1. Xanthine oxidase inhibitor febuxostat as a novel agent postulated to act against vascular inflammation.
    Sabán-Ruiz J; Alonso-Pacho A; Fabregate-Fuente M; de la Puerta González-Quevedo C
    Antiinflamm Antiallergy Agents Med Chem; 2013; 12(1):94-9. PubMed ID: 23286293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Febuxostat suppressed renal ischemia-reperfusion injury via reduced oxidative stress.
    Tsuda H; Kawada N; Kaimori JY; Kitamura H; Moriyama T; Rakugi H; Takahara S; Isaka Y
    Biochem Biophys Res Commun; 2012 Oct; 427(2):266-72. PubMed ID: 22995295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Febuxostat, an inhibitor of xanthine oxidase, suppresses lipopolysaccharide-induced MCP-1 production via MAPK phosphatase-1-mediated inactivation of JNK.
    Nomura J; Busso N; Ives A; Tsujimoto S; Tamura M; So A; Yamanaka Y
    PLoS One; 2013; 8(9):e75527. PubMed ID: 24086554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral ureteral obstructive nephropathy.
    Omori H; Kawada N; Inoue K; Ueda Y; Yamamoto R; Matsui I; Kaimori J; Takabatake Y; Moriyama T; Isaka Y; Rakugi H
    Clin Exp Nephrol; 2012 Aug; 16(4):549-56. PubMed ID: 22350467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Febuxostat inhibition of endothelial-bound XO: implications for targeting vascular ROS production.
    Malik UZ; Hundley NJ; Romero G; Radi R; Freeman BA; Tarpey MM; Kelley EE
    Free Radic Biol Med; 2011 Jul; 51(1):179-84. PubMed ID: 21554948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Febuxostat, a novel xanthine oxidoreductase inhibitor, improves hypertension and endothelial dysfunction in spontaneously hypertensive rats.
    Shirakura T; Nomura J; Matsui C; Kobayashi T; Tamura M; Masuzaki H
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):831-8. PubMed ID: 27198514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xanthine oxidase mediates axonal and myelin loss in a murine model of multiple sclerosis.
    Honorat JA; Kinoshita M; Okuno T; Takata K; Koda T; Tada S; Shirakura T; Fujimura H; Mochizuki H; Sakoda S; Nakatsuji Y
    PLoS One; 2013; 8(8):e71329. PubMed ID: 23951137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice.
    Nomura J; Busso N; Ives A; Matsui C; Tsujimoto S; Shirakura T; Tamura M; Kobayashi T; So A; Yamanaka Y
    Sci Rep; 2014 Apr; 4():4554. PubMed ID: 24686534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose dysmetabolism, and prothrombotic state in mice.
    Yisireyili M; Hayashi M; Wu H; Uchida Y; Yamamoto K; Kikuchi R; Shoaib Hamrah M; Nakayama T; Wu Cheng X; Matsushita T; Nakamura S; Niwa T; Murohara T; Takeshita K
    Sci Rep; 2017 Apr; 7(1):1266. PubMed ID: 28455534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic xanthine oxidase inhibition following myocardial infarction in rabbits: effects of early versus delayed treatment.
    Zhao L; Roche BM; Wessale JL; Kijtawornrat A; Lolly JL; Shemanski D; Hamlin RL
    Life Sci; 2008 Feb; 82(9-10):495-502. PubMed ID: 18215719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Febuxostat ameliorates diabetic renal injury in a streptozotocin-induced diabetic rat model.
    Lee HJ; Jeong KH; Kim YG; Moon JY; Lee SH; Ihm CG; Sung JY; Lee TW
    Am J Nephrol; 2014; 40(1):56-63. PubMed ID: 25034030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of xanthine oxidase by the aldehyde oxidase inhibitor raloxifene: implications for identifying molybdopterin nitrite reductases.
    Weidert ER; Schoenborn SO; Cantu-Medellin N; Choughule KV; Jones JP; Kelley EE
    Nitric Oxide; 2014 Feb; 37():41-5. PubMed ID: 24406683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xanthine Oxidoreductase Inhibitors.
    Vickneson K; George J
    Handb Exp Pharmacol; 2021; 264():205-228. PubMed ID: 32789757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase.
    Takano Y; Hase-Aoki K; Horiuchi H; Zhao L; Kasahara Y; Kondo S; Becker MA
    Life Sci; 2005 Mar; 76(16):1835-47. PubMed ID: 15698861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model.
    Nakatsu Y; Seno Y; Kushiyama A; Sakoda H; Fujishiro M; Katasako A; Mori K; Matsunaga Y; Fukushima T; Kanaoka R; Yamamotoya T; Kamata H; Asano T
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G42-51. PubMed ID: 25999428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardio-renal protective effect of the xanthine oxidase inhibitor febuxostat in the 5/6 nephrectomy model with hyperuricemia.
    Omizo H; Tamura Y; Morimoto C; Ueno M; Hayama Y; Kuribayashi-Okuma E; Uchida S; Shibata S
    Sci Rep; 2020 Jun; 10(1):9326. PubMed ID: 32518351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human and rodent red blood cells do not demonstrate xanthine oxidase activity or XO-catalyzed nitrite reduction to NO.
    Lewis SE; Rosencrance CB; De Vallance E; Giromini A; Williams XM; Oh JY; Schmidt H; Straub AC; Chantler PD; Patel RP; Kelley EE
    Free Radic Biol Med; 2021 Oct; 174():84-88. PubMed ID: 34273539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term inhibition of xanthine oxidase by febuxostat does not decrease blood pressure in deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Szasz T; Davis RP; Garver HS; Burnett RJ; Fink GD; Watts SW
    PLoS One; 2013; 8(2):e56046. PubMed ID: 23393607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced XOR activity in eNOS-deficient mice: Effects on the nitrate-nitrite-NO pathway and ROS homeostasis.
    Peleli M; Zollbrecht C; Montenegro MF; Hezel M; Zhong J; Persson EG; Holmdahl R; Weitzberg E; Lundberg JO; Carlström M
    Free Radic Biol Med; 2016 Oct; 99():472-484. PubMed ID: 27609225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydralazine improves ischemia-induced neovasculogenesis via xanthine-oxidase inhibition in chronic renal insufficiency.
    Chang TT; Chen JW
    Pharmacol Res; 2020 Jan; 151():104509. PubMed ID: 31678640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.